Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 955-212-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 6th of August to 5th of November, 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- other information
- Reason / purpose for cross-reference:
- read-across: supporting information
- Remarks on result:
- not measured/tested
- Remarks:
- This end-point is read across to a structuraly similar substance.
- Critical effects observed:
- no
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- (Z)-N-octadec-9-enylhexadecan-1-amide
- EC Number:
- 240-367-6
- EC Name:
- (Z)-N-octadec-9-enylhexadecan-1-amide
- Cas Number:
- 16260-09-6
- Molecular formula:
- C34H67NO
- IUPAC Name:
- N-octadec-9-en-1-ylhexadecanamide
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Substance: N-octadec-9-en-1-ylhexadecanamide (EC 240-367-6)
- Colour: white
- Storage: ambient
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Wistar, derived SPF- Albino, Crt: Wi/Br
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Versuchstierzucht, Charles River Wiga, 8741 Sulzfeld
- Age at study initiation: about 5 weeks (born the 1st and 2st July, 1987)
- Weight at study initiation: Males from 129 g to 170 g; Females from 115 g to 138 g
- Date of receipt: July 30th, 1987
- Animal health: at the entrance, at the test initiation. Certification available.
- Housing: in makrolon R cages.
- Bedding: "Altromin Laboreinstreu" of pure soft wood, dried, disdusted and sterilized at 180°C, supplied by Altromin GmbH, 4937 Lage, renewed weekly.
- Diet: Ssniff R pelletted diet (standard laboratory rat diet), ad libitum
- Diet quality assurance: diet analysed periodically from chlorinated hydrocarbons, aflatoxins, heavy metals, arsenic, and antibiotic activity (by "Landwirtschaf tliche Untersuchungs' und Forschungsanstalt - Kiel" (LUFA, independent laboratory). Certification avalaible.
- Water: tap water from Makrolon R drinking bottles, ad libitum
- Water quality assurance: water was collected twice yearly and analysed from analyses for chlorinated hydrocarbons, heavy metals and arsenic according to "Trinkwasserverordnung" by a governmental chemical institute for chemical quality. Water was controlled bacteriologically by governmental institute for public health. Certification available.
- Acclimation period: 7 days
- Justification for the choice of the species: standard experimental animal
- Animal identification: marked by numbered ear tags and individual cage cards (project number, test group, animal number, ear tag number, source, stain, sex, date of receipt)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.5 °C ± 1.5 °C
- Humidity (%): 65 % ± 10 %
- Recording: by thermohygrograph
- Air changes (per hr): 16 times
- Photoperiod (hrs dark / hrs light): 12/24 from 7.00 a.m to 7.00 p.m.
- Intensity of light: 120 lux
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: basal diet ( incorporation in pellet)
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS DIET PREPARATION
- Rate of preparation of diet: the mixtures were prepared for the first 6 study weeks and again for the 6-13 weeks study phase.
- Mixing: test compound was weighted out for each concentration level and mixed with a small amount of basal diet (300 g), in a pulverized form. Mixing was continued in three steps to the final quantity. Each preparation was pelleted and identified.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- - Randomized collected samples from each batch and dose level were analysed for N-Oleyl Palmitamide concentrations (Identity, concentration, homogeneity and stability) by Dr. J.G.A. Kooyman, Clo AKZO Chemicals, Netherland BV, Research Centre Deventer, Analytical Department, Deventer.
- Results: the N-Oleyl Palmitamide concentrations were within a range of 10% of the target, homogeneity was within 10% of the average of Samples and stability was not deviating more than 7% of the originally determined average content.
- Basal diet (control) samples were analyzed to confirm the absence of N-Oleyl Palmitamide.
- Stability of the high concentration was tested after storage of the diet for 6 weeks and 4 months. - Duration of treatment / exposure:
- 13 weeks
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
1200
Basis:
other: dietary concentration of N-Oleyl Palmitamide (ppm)
- Remarks:
- Doses / Concentrations:
6000
Basis:
other: dietary concentration of N-Oleyl Palmitamide (ppm)
- Remarks:
- Doses / Concentrations:
12000
Basis:
other: dietary concentration of N-Oleyl Palmitamide (ppm)
- No. of animals per sex per dose:
- 40 male/40 female
4 test groups of 10 male and 10 female animals - Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Rationale for animal assignment: random, by a computerized randomization table (from both sexes)
Examinations
- Observations and examinations performed and frequency:
- CLINICAL OBSERVATION
All animals were observed daily with regard to their Sensory and motor behaviour, hair coat, body orifices, urine and faecal excretion, for their general health status and dose responses. The observations were recorded daily and dose responses were summarized in weekly reports. Viability or mortality checks, resp., were performed twice daily.
SPECIAL CLINICAL EXAMINATION (by Dr. Trinks)
Prior to initiation, after 6 weeks and at termination:
- Ophthalmologic examinations: (cornea, episceral vessels, anterior chamber, pupil, lens, retina) using an ophthalmoscope
- The hearing, tested by simple noise production
- The reflex (awareness, emotion, coordination, autonomic functions)
In weekly intervals:
- Bodyweights, food consumption, water consumption
At the end of the test:
- Moribund animals/mortalities
- Complete macroscopic autopsy
- Organs observations
LABORATORY EXAMINATION (IBR laboratory)
After 6 weeks and at termination
- Hematologiacal and clinical chemistry investigations (samples from retrobulbar venous plexus)
- Urine collection (collected in 18 hours after 20 ml/Kg intragastric administration of water) - Sacrifice and pathology:
- NECROPSY
All surviving animals were sacrificed at the end of the experiment by C02 asphyxiation.
A complete autopsy was performed for each animal, with the order of necropsy performed in a random manner (macropathological observations, registration of any abnormal findings)
DETERMINATION OF ORGAN WEIGHTS - Other examinations:
- HISTOPATHOLOGICAL EXAMINATIONS (after organ fixation and tissue preparation)
- Statistics:
- Scheffè method for weight changes, food consumption and water consumption
Co-variance analysis and Scheffè method for organ weights
Variance analysis for dose-effect curves and Scheffè method for clinical chemistry and hematology
Results are expressed with the mean values per group and the standard deviation.
For bodyweights the percentage is calculated.
All control mean values are equalized with 100 %.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- Special reflex examinations after 6 weeks and at termination did not reveal any differences between control- and dose group animals
- Mortality:
- no mortality observed
- Description (incidence):
- Special reflex examinations after 6 weeks and at termination did not reveal any differences between control- and dose group animals
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Slight variations among groups were within a range of 10 % to the controls and, since there was no evidence of dose-relation
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- Some sporadic differences were not dose-related and thus considered to be coincidental.
- Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- Occasionally occurring significant differences to the concurrent control group were not specifically dose-related
- Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- The significant decrease of specific gravity in dose group III (males) after 6 weeks was not dose-related
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- Some incidental spontaneous changes were nearly equally distributed among control and dose group animals
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- Some spontaneous incidental lesions or lesions due to sacrifice were found
- Histopathological findings: neoplastic:
- not examined
Effect levels
open allclose all
- Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- other: dietary concentration
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
- Dose descriptor:
- NOEL
- Effect level:
- 12 000 ppm
- Based on:
- other: dietary concentration
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The test material was incorporated into pelleted rat standard laboratory diet at concentrations of 1200 ppm (dose group I), 6000 ppm (dose group II) and 12000 ppm (dose group III), to perform a test according to OECD 408.
These dietary concentrations were designed to provide daily dose levels of 100, 500, and 1000 mg/kg/day.
A concurrent control group received the basal diet only. Eachgroup consisted of 10 Wistar-rats per sex. The rats were exposed to the testcompound over an entire test period of 13 weeks. Analytical chemistry results indicated that the mixing procedure resulted in homogeneous mixtures of the test material in the diet. Periodic analyses during the study found the concentrations of test material in the diet to be within acceptable limits. A stability study conducted at the high concentration after storage for up to 4 months indicated that the test material was stabile in the diet. Under the experimental conditions of the study the test material had no adverseeffects on clinical signs, bodyweights, food consumption, water consumption,hematology, clinical chemistry, organs weights, and histopathology.
The "no-effect" - level of the test material was at a dietary concentrationof 12000 ppm, when fed to rats of the Wistar-strain over an entire test period of 13 weeks.
This no-adverse effect level correlates with a mean test compound intake of approximately 1000 mg/Kg/day.
Samples from all tissues listed below were removed from all animals; blocks and slides were prepared and examined for the control and high dose groups: skin, mammary gland, salivary gland, trachea, esophagus, thyroid (2x), parathyroid (2x), thymus, heart, lung, aorta, pituitary, tongue, liver, spleen, pancreas, kidney (2x), adrenal (2x), stomach, duodenum, jejunum, ileum, cecum, colon, seminal vesicle, lymph node (mesenteric+ cervical), ovary (2x)/ testis + epididymis (2x), prostate/uterus + vagina, urinary bladder, sciatic nerve, skeletal muscle, bone with marrow (sternum + femur), eye with N. opticus (2x), cerebrum with brain stem, cerebellum, spinal cord (2x), lacrimal gland (2x), macroscopic changes.
Microscopic evaluation of representative organ sections from all control and high dose animals did not reveal any test item related changes. Some spontaneous incidental lesions or lesions due to sacrifice were found evenly distributed among control and high dose animals of both sexes.
Applicant's summary and conclusion
- Conclusions:
- The results of this study indicate, that the test material had no adverse effect on any of the tested parameters in rats of the Wistar-strain over the entire test period of 13 weeks. Thus a dietary concentration of 12000 ppm (high-dose group) revealed a clear "no-effect" level.
Significant intergroup differences in individual parameters were generally within normal limits and without any dose-relationship. These differences are therefore considered to be without biological importance and not attributable to the test material exposure. - Executive summary:
In an OECD 408 study, conducted according to GLP, the sub-chronic toxicity of the structurally similar read across substance in male and female Wistar rats a NOAEL of greater than or equal to 1,000 mg/kg/d was determined. The lack of test item related changes in the reproductive organs, accessory sexual organs, pituitary, adrenal gland, and thyroid provides evidence that the substance lacks the potential to cause reproductive toxicity and no treatment-related histopathological, haematological or clinical effects were observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.